image
By Asia Education Review Team , Monday, 27 May 2024

Dubai launches Young Scientists Summit for Clinical Sciences

  • The Young Scientists Summit in Laboratory Medicine and Clinical Sciences, organized by the Emirates Society for Genetic Diseases, commenced in Dubai, with Sheikh Theyab bin Khalifa bin Shakhbut Al Nahyan in attendance. The event drew 300 young scientists and researchers from 55 countries, along with 62 heads of scientific organizations and institutions.

    This summit is held alongside the 26th International Summit of Clinical Chemistry and Genetic Diseases and the 17th Arab Federation of Biochemistry Summit. Both events are hosted by the UAE in Dubai and organized by the Emirates Society for Genetic Diseases at the Dubai World Trade Center.

    In his opening speech, Sheikh Theyab bin Khalifa bin Shakhbut Al Nahyan expressed the UAE's pride in hosting such a significant scientific event. He emphasized the summit's goal of enhancing research cooperation between the UAE and international researchers. Sheikh Theyab highlighted the UAE's capability to host global events due to its logistical and geographical advantages. He also mentioned that the UAE's health sector benefits from the attention and support of the country's leadership, making it one of the best in the world in healthcare.

    Sheikh Theyab also noted the UAE's wise leadership's support for youth, particularly in scientific and medical research. He encouraged the country's youth to be well-versed in global knowledge and advancements.

    The summit features participation from numerous specialized universities and scientific colleges in the UAE and addresses six scientific topics presented for the first time in the local and Gulf region. These topics are delivered by a select group of young scientists from around the world, aiming to exchange experiences, explore new research areas, and embody a new vision in genetic medicine.

    Participants include decision-makers, patients and their families, specialists from health and social services, policymakers, and health insurance companies, all in an interactive environment to foster collaboration and innovation in the field of genetic medicine.